Target intelligence / Profile preview

Inactive dipeptidyl peptidase 10 (DPP10)

Target
DPP10
Molecular classification
Other (single-pass type II membrane protein), S9B serine protease subfamily (inactive), Accessory subunit to voltage-gated potassium channels
01

Overview

Inactive dipeptidyl peptidase 10 (DPP10) is a single-pass type II membrane glycoprotein of the S9B serine protease subfamily, rendered enzymatically inactive by the substitution of a catalytic serine in its active site[1][3]. Despite lacking protease function, DPP10 serves as an essential auxiliary subunit that binds to and modulates the biophysical properties, expression, and localization of specific voltage-gated potassium channels, particularly Kv4.x family members[1][2]. DPP10’s activity influences neuronal excitability and airway epithelial physiology; it has key roles in regulating ion channel gating kinetics and facilitating cell surface localization of the channels[1][2][3]. Genetic variants or mutations in DPP10 are associated with asthma, neurodegenerative diseases (including Alzheimer’s and frontotemporal dementia), and autism spectrum disorders[2][3]. The absence of protease activity makes DPP10 unique among dipeptidyl peptidases, and its primary molecular role is in protein-protein interaction rather than catalysis[1][2][3]. There are currently no approved drugs known to interact directly with DPP10, nor established clinical biomarkers or mechanisms of action through inhibition/activation, but the protein is being studied for its role as a modulator of ion channel complexes and as a biological link to respiratory and neurological conditions[1][2][3].

Other names
DPRP3KIAA1492DPP XDPL2DPPYDipeptidyl peptidase IV-related protein 3Dipeptidyl peptidase XDipeptidyl peptidase-like protein 2DPRP-3
02

Biological functions

Modulation of voltage-gated potassium channel function and traffickingRegulation of neuronal excitabilityInfluences protein localization to the plasma membraneRegulation of potassium ion transmembrane transportModulation of electrophysiological properties of cells
03

Disease associations

AsthmaNeurodegenerative diseases (e.g., Alzheimer’s disease, frontotemporal dementia)Autism spectrum disordersInflammation (potential role suggested in airway inflammation)
04

Safety considerations

Possible implications in neurological and respiratory diseases if targeted or modulatedNo known direct safety concerns as a drug target due to lack of enzymatic activity

Beyond the preview

Go deeper on Inactive dipeptidyl peptidase 10 (DPP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inactive dipeptidyl peptidase 10 (DPP10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call